
Paul Kiptoo
A Ph.D level Scientist with experience in protein characterization including recombinant monoclonal antibodies (mAbs) using various LC-MS... | Greater Boston, Greater Boston, United States
*50 free lookup(s) per month.
No credit card required.
Paul Kiptoo’s Emails pa****@sa****.com
Paul Kiptoo’s Phone Numbers No phone number available.
Social Media
Paul Kiptoo’s Location Greater Boston, Greater Boston, United States
Paul Kiptoo’s Expertise A Ph.D level Scientist with experience in protein characterization including recombinant monoclonal antibodies (mAbs) using various LC-MS and LC-MS/MS platforms. Expert in LC-MS and LC-MS/MS method development using various platforms such Waters Synapt-G2, Waters Xevo G2-XS, Waters TQS, SCIEX 4000 and 5500 QTRAPs, and Agilent 6545 Q-TOF. In-depth knowledge and experience in intact protein and subunit analysis as well as peptide-mapping. Experienced in characterization of post-translational modifications (PTMs) of mAbs using LC-MS/MS. Solid understanding in the principles underlying PTMs of proteins as well as the design and execution of forced degradation studies to evaluate and profile protein degradation pathways using LC-MS and LC-MS/MS. Experienced in identification and relative quantification of released glycans labeled with 2-AB or RapiFLuor using FLD and LC-MS. Experienced in the analysis of glycoforms at a subunit level after digestion with enzymes such as FabRICATOR (IdeS), PNGase F, and Endo H. Analysis of glycoforms at a glycopeptide level for glycosylation profiling and site occupancy determination. Skilled in analytical techniques such as reverse-phase liquid chromatography and its use in peptide-mapping and glycan analysis (e.g., glycosylation profiling and site occupancy determination), HIC for isolation and analysis of chemically modified proteins, HILIC for released glycan analysis, Cation exchange (CEX) for the isolation and characterization of acidic and basic variants in forced degradation studies, and size exclusion chromatography (SEC) for the analysis of protein aggregates and fragments. Scientific peer reviewer for molecular pharmaceutics, advanced drug delivery, and journal of pharmacy and pharmacology. Skilled in writing and reviewing manuscripts, patents, protocols, analytical methods, and SOPs
Paul Kiptoo’s Current Industry Sanofi
Paul
Kiptoo’s Prior Industry
University Of Kentucky
|
University Of Kansas
|
Sekisui Xenotech
|
Seqirus
|
Sanofi
Not the Paul Kiptoo you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Sanofi
Scientist
Fri Oct 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Seqirus
QC Specialist
Sun Mar 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Oct 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Sekisui Xenotech
Research Scientist
Fri Jul 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Mar 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
University Of Kansas
Research Associate
Mon Oct 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Jun 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
University Of Kentucky
Graduate Research Assistant
Thu Aug 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Oct 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time)